Hemophilia gene therapy represents a groundbreaking advance in the treatment of hemophilia, offering hope to patients who have long battled this genetic bleeding disorder.With innovative treatments like Hemgenix, which received FDA approval in late 2022, there is a renewed optimism surrounding gene therapy for hemophilia.